Business Context and Reporting Period
This Form 8-K Current Report was filed by Cushman & Wakefield plc on January 5, 2021. The filing discloses the appointment of a new Chief Financial Officer and details the associated compensatory arrangements.
Key Financial Metrics
This filing does not contain revenue, profit, cash flow, margin, debt, or liquidity metrics. It focuses exclusively on executive compensation terms.
- Annual Base Salary: $600,000
- Target Annual Bonus: $600,000 (200% of target possible for extraordinary results)
- 2021 Bonus Guarantee: Minimum of $600,000
- Sign-on Bonus: $250,000 (payable October 2021, subject to continued employment)
- Long-Term Equity Incentives: Fair value of $2,200,000
- Consulting Rate (Interim): $600,000 annualized (prorated for Jan 18 - Feb 28, 2021)
Material Changes
The primary material change is the leadership transition in the finance function:
- Appointment: Neil Johnston appointed as Chief Financial Officer, effective February 28, 2021.
- Departure: Duncan Palmer will retire as CFO, replaced by Mr. Johnston.
- Interim Role: Mr. Johnston serves as a consultant from January 18, 2021, until his official start date.
Outlook, Risks, and Unusual Items
Management Commentary: The filing includes a standard forward-looking statements disclaimer, noting that future plans and estimates are subject to risks and uncertainties detailed in the Company's Form 10-K and 10-Q filings.
Compensation Terms: In the event of termination without cause, Mr. Johnston is entitled to twelve months' salary plus a prorated annual cash incentive award. The agreement includes customary confidentiality and non-solicitation covenants.
Unusual Items: The filing notes there are no related person transactions between Mr. Johnston and the Company.
Investor Verification Checklist
- Verify the exact effective date of the CFO transition (February 28, 2021) and the interim consulting period.
- Confirm the total potential cash compensation for 2021, including the guaranteed bonus and sign-on bonus.
- Review the terms of the long-term equity grants ($2.2M fair value) for vesting schedules and performance conditions.
- Check the Company's most recent Form 10-K or 10-Q for broader financial context not included in this 8-K.